Last reviewed · How we verify

NCT03817177

Application of High Flow Nasal Cannula for Prevention of Post-extubation Atelectasis in Children Undergoing Surgery

Status unknown NA Last updated 7 March 2019
What this trial tests

NA trial testing high flow nasal cannula oxygenation in Atelectasis in 80 participants. Status unknown.

Timeline
2 March 2019
Primary endpoint
30 January 2021
30 June 2021

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment80
Start date2 March 2019
Primary completion30 January 2021
Estimated completion30 June 2021
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Adults 1 Day to 2, any sex, with Atelectasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

postoperative atelectasis observation by ultrasound after application of high flow nasal cannula oxygenation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atelectasis

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03817177.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing